Resumo

ORTIZ LEGRA, Ruber; PEREZ CASTILLO, Mayvi  e  PENA BATISTA, Andrés Pavel. Low molecular weight heparin-induced thrombocytopenia in a patient with COVID-19. Medisur [online]. 2022, vol.20, n.1, pp. 146-153.  Epub 28-Fev-2022. ISSN 1727-897X.

Although the respiratory system is the most affected by COVID-19, today we know that it also predisposes to thromboembolic disease, due to the excessive inflammation, platelet activation, endothelial dysfunction and stasis that it usually causes. The prophylactic application of low molecular weight heparins has been one of the main recommendations in patients hospitalized for this health emergency, a practice that is not exempt from secondary events, and which has thrombocytopenia among its most serious complications. In order to alert about the appearance of this entity and avoid further complications, a case is presented in which thrombocytopenia was found after receiving seven doses of enoxaparin, and after 48 hours of suspending this, the progressive rise of platelets in number began, until they reach their normal levels.

Palavras-chave : Coronavirus infections; thrombocytopenia; heparin, low-molecular-weight.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )